Inside Johnson & Johnson’s secret plan to cap litigation payouts to cancer victims

If J&J succeeds, some experts argue, it could provide a blueprint for corporate America on how to circumvent jury trials involving allegations of defective products ...

参照元：Japan Times latest articles